CRI Genetics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CRI Genetics's estimated annual revenue is currently $7.4M per year.(i)
  • CRI Genetics's estimated revenue per employee is $155,000

Employee Data

  • CRI Genetics has 48 Employees.(i)
  • CRI Genetics grew their employee count by 4% last year.

CRI Genetics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Operations OfficerReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Head MarketingReveal Email/Phone
5
Operations ManagerReveal Email/Phone
6
Customer Service Team ManagerReveal Email/Phone
7
Certified Public AccountantReveal Email/Phone
8
Full Stack Developer Team LeadReveal Email/Phone
9
Technical WriterReveal Email/Phone
10
Full Stack DeveloperReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is CRI Genetics?

Our mission at CRI Genetics (Cellular Research Institute, Genetics Department) is to unlock complex information from your DNA and present it to you in a way that’s interesting, useful, and easy to understand. We want to help you learn more about yourself and find ways to improve your life through genetic testing. Our primary goal is to improve human life and further Mankind’s understanding of the human genome. Not only do we provide advanced genetic reports to consumers, but we also actively participate in scientific research. We believe genetic analysis is the future of medicine and we’re excited to play a role in solving complex medical problems.

keywords:N/A

N/A

Total Funding

48

Number of Employees

$7.4M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.9M482%N/A
#2
$9M48-9%N/A
#3
$5.6M4817%N/A
#4
$6.3M4814%N/A
#5
$4.7M48-24%$30.5M